These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24162840)

  • 1. Resection of residual disease after isolated limb infusion (ILI) is equivalent to a complete response after ILI-alone in advanced extremity melanoma.
    Wong J; Chen YA; Fisher KJ; Beasley GM; Tyler DS; Zager JS
    Ann Surg Oncol; 2014 Feb; 21(2):650-5. PubMed ID: 24162840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.
    Miura JT; Kroon HM; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Kim Y; Naqvi SMH; Potdar A; Daou H; Sun J; Farma JM; Henderson MA; Speakman D; Serpell J; Delman KA; Mark Smithers B; Coventry BJ; Tyler DS; Thompson JF; Zager JS
    Ann Surg Oncol; 2019 Aug; 26(8):2486-2494. PubMed ID: 30911949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of recurrence following complete response to regional chemotherapy for in-transit melanoma.
    Sharma K; Beasley G; Turley R; Raymond AK; Broadwater G; Peterson B; Mosca P; Tyler D
    Ann Surg Oncol; 2012 Aug; 19(8):2563-71. PubMed ID: 22476748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma.
    Dossett LA; Ben-Shabat I; Olofsson Bagge R; Zager JS
    Ann Surg Oncol; 2016 Jul; 23(7):2330-5. PubMed ID: 26926481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australian Multicenter Study of Isolated Limb Infusion for Melanoma.
    Kroon HM; Coventry BJ; Giles MH; Henderson MA; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Coventry AG; Sullivan T; Smithers BM; Thompson JF
    Ann Surg Oncol; 2016 Apr; 23(4):1096-103. PubMed ID: 26581203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in China.
    Li S; Sheng X; Si L; Cui C; Kong Y; Mao L; Lian B; Tang B; Yan X; Wang X; Chi Z; Guo J
    Ann Surg Oncol; 2018 Apr; 25(4):885-893. PubMed ID: 29270879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with response, survival, and limb salvage in patients undergoing isolated limb infusion.
    Steinman J; Ariyan C; Rafferty B; Brady MS
    J Surg Oncol; 2014 Apr; 109(5):405-9. PubMed ID: 24318953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion.
    Beasley GM; Petersen RP; Yoo J; McMahon N; Aloia T; Petros W; Sanders G; Cheng TY; Pruitt SK; Seigler H; Tyler DS
    Ann Surg Oncol; 2008 Aug; 15(8):2195-205. PubMed ID: 18528730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated limb infusion for advanced soft tissue sarcoma of the extremity.
    Moncrieff MD; Kroon HM; Kam PC; Stalley PD; Scolyer RA; Thompson JF
    Ann Surg Oncol; 2008 Oct; 15(10):2749-56. PubMed ID: 18648882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanoma.
    Coventry BJ; Kroon HM; Giles MH; Henderson M; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Coventry AG; Sullivan T; Smithers BM
    J Surg Oncol; 2014 Jun; 109(8):780-5. PubMed ID: 24634160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities.
    Chai CY; Deneve JL; Beasley GM; Marzban SS; Chen YA; Rawal B; Grobmyer SR; Hochwald SN; Tyler DS; Zager JS
    Ann Surg Oncol; 2012 May; 19(5):1637-43. PubMed ID: 22143576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center study.
    Kroon HM; Coventry BJ; Henderson MA; Barbour A; Serpell J; Smithers BM; Thompson JF
    Eur J Surg Oncol; 2019 May; 45(5):832-837. PubMed ID: 30867095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma.
    Muilenburg DJ; Beasley GM; Thompson ZJ; Lee JH; Tyler DS; Zager JS
    Ann Surg Oncol; 2015 Feb; 22(2):482-8. PubMed ID: 25192683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients.
    Teras J; Kroon HM; Miura JT; Kenyon-Smith T; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Potdar A; Daou H; Sun J; Carr M; Farma JM; Henderson MA; Speakman D; Serpell J; Delman KA; Smithers BM; Barbour A; Tyler DS; Coventry BJ; Zager JS; Thompson JF
    Ann Surg Oncol; 2020 May; 27(5):1420-1429. PubMed ID: 32152775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes following isolated limb infusion for melanoma. A 14-year experience.
    Kroon HM; Moncrieff M; Kam PC; Thompson JF
    Ann Surg Oncol; 2008 Nov; 15(11):3003-13. PubMed ID: 18509706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma.
    Kroon HM; Lin DY; Kam PC; Thompson JF
    Cancer; 2009 May; 115(9):1932-40. PubMed ID: 19288571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of isolated limb infusion in limb threatening extremity sarcomas.
    Vohra NA; Turaga KK; Gonzalez RJ; Conley A; Reed D; Bui MM; Cheong D; Letson DG; Zager JS
    Int J Hyperthermia; 2013; 29(1):1-7. PubMed ID: 23205633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion.
    Beasley GM; Sharma K; Wong J; Miller M; Turley RS; Lidsky M; Masoud M; Dewhirst MW; Mosca PJ; Zager JS; Tyler DS
    Cancer; 2012 Dec; 118(24):6136-43. PubMed ID: 22674423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does increased experience with isolated limb infusion for advanced limb melanoma influence outcome? A comparison of two treatment periods at a single institution.
    Huismans AM; Kroon HM; Kam PC; Thompson JF
    Ann Surg Oncol; 2011 Jul; 18(7):1877-83. PubMed ID: 21499810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft-tissue sarcoma of the extremity: final report of a phase II clinical trial.
    Brady MS; Brown K; Patel A; Fisher C; Marx W
    Melanoma Res; 2009 Apr; 19(2):106-11. PubMed ID: 19282789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.